← Leaderboards
Andrea Moffitt
Cold Spring Harbor Laboratory
$1,096,204
Attributed
$1,096,204
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $316.1K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,096,204 · 2
By mechanism
R00$846,728 · 1
K99$249,476 · 1
Top collaborators
No co-investigators on record.
Most similar at Cold Spring Harbor Laboratory
Same institution · by research overlap
- Christopher Vakoc$22,318,597
- Lincoln D Stein$40,708,138
- Alexander Dobin$2,400,000
- Joshua T Dubnau$17,193,741
- Michael H Wigler$15,095,424
Others in their field
Other Emerging Leaders on “Treatment Response”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Prasant Mohapatra · University Of California At Davis$52,567,812
- Susan M Landau · University Of California Berkeley$47,252,026
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
Treatment ResponseResidual NeoplasmLeukemiaGenomicsAftercareBiologicalComputational AlgorithmCommunicationCostBurden Of IllnessBenchmarkingCancer GenomicsCancer PatientCancer TypeCellsBloodCell Free DnaCell TypeBlood SpecimenAcute Myelocytic LeukemiaClinical ResearchClinical TranslationCancer BiologyCareer Development
Grant awards (7)
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$249,000
R00 · FY2025 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$67,085
R00 · FY2025 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$227,958
R00 · FY2024 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$53,685
R00 · FY2024 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$249,000
R00 · FY2023 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$124,738
K99 · FY2021 · CA · contact PI
Measuring treatment response and residual disease in leukemia with personalized, sensitive, and quantitative genomic methods$124,738
K99 · FY2020 · CA · contact PI